⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for enzyme inhibitor

Every month we try and update this database with for enzyme inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)NCT00700206
Myelodysplastic...
Ezatiostat Hydr...
18 Years - Telik
Study of (Telintra®) in Non-Del(5q) Myelodysplastic SyndromeNCT01459159
Myelodysplastic...
ezatiostat hydr...
18 Years - Telik
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.NCT01844765
Philadelphia Po...
nilotinib
1 Year - 17 YearsNovartis
Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)NCT00700206
Myelodysplastic...
Ezatiostat Hydr...
18 Years - Telik
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationNCT04699188
KRAS G12C Mutan...
Carcinoma, Non-...
Carcinoma, Colo...
Cancer of Lung
Cancer of the L...
Lung Cancer
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
JDQ443
TNO155
tislelizumab
18 Years - Novartis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: